News

Following the positive opinion, the World Health Organization (WHO) will now formulate a policy recommendation on use of the vaccine in national immunization programs once approved by national

Technivie is an all-oral, interferon-free, direct-acting antiviral treatment consisting of the fixed-dose combination of paritaprevir/ritonavir (150/100mg) co-formulated with ombitasvir (25mg) dosed once daily and taken with a meal,

Naramin relieves the symptoms of hayfever/allergy including sneezing, runny nose, itchy watery eyes and itchy throat. It’s easy to carry for people on-the-go when you fly, camp, fish

This 505(b)(2) NDA requests FDA approval of Eagle’s RTU bivalirudin product for the treatment of patients: undergoing percutaneous coronary intervention (PCI) with use of glycoprotein IIb/IIIa inhibitor, undergoing

The proprietary combination of salts and amino acids has been engineered to create small and dense particles possessing properties that have the potential to enable or improve new

Based on the results presented at the biannual meeting July 10th in Heidelberg, Germany, Merck Serono decided to extend the funding of the first two international research groups

The EMA will initiate review of the MAA under accelerated assessment timelines. "Given the diversity of patient populations affected by chronic hepatitis C, including the estimated 15 million

HTX-011 is a long-acting formulation of the local anesthetic bupivacaine in a fixed-dose combination with the anti-inflammatory meloxicam. Around 60 patients undergoing inguinal hernia repair will be included

As part of the deal, PharmaMar will receive an upfront payment, royalties and additional remunerations for regulatory milestones achieved by Aplidin. The deal will see PharmaMar retain exclusive